Innovation in Biopharma Education
The Jefferson Institute for Bioprocessing is up and running after just two years. How did they do it? What courses are on offer? And how do its leaders see biopharma training developing in the coming years?
James Strachan | | Interview
It was Saint Patrick’s Day 2016 when J&J’s Mary Lynne Bercik was listening to Dominic Carolan, CEO of Ireland’s National Institute of Bioprocessing Research and Training (NIBRT) at DCAT in New York City. Carolan was explaining NIBRT’s approach to training the biopharmaceutical workforce of the future. NIBRT is a fully functional pilot manufacturing facility dedicated to training and research (see sidebar, “Who or what is NIBRT?”). Bercik, who had graduated from Thomas Jefferson University’s business school, wondered whether it might be possible to mirror NIBRT’s efforts in the US – the “spark” that ultimately led to the Jefferson Institute for Bioprocessing (JIB), which is now up and running just years two since the collaboration was first announced in 2017.
The JIB delivers NIBRTs curriculum in Philadelphia. And, like NIBRT, it is open to industry professionals who want to take part in workshops and courses, as well as graduate and undergraduate students in bioprocess engineering – one difference is that Jefferson, being a university, can incorporate courses into its degree programs.
Following our coverage of the Jefferson-NIBRT collaboration last year (1), we speak once again to Ron Kander, Executive Dean of Jefferson’s Kanbar College of Design, Engineering and Commerce, and to the new Executive Director and Head of the Jefferson Institute for Bioprocessing, Parviz Shamlou, to find out how the institute launched so quickly – and their plans are for the future.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.